Evidence map›Paper›PMID 29701706›Full record

ArticleMolecules (Basel, Switzerland)2018

Anticancer Profiling for Coumarins and Related

Mohammed A Baghdadi, Fahad A Al-Abbasi, Ali M El-Halawany, Ali H Aseeri, Ahmed M Al-Abd

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The Inhibitory Effect of KerraMedicina (Kaunas, Lithuania) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. The Effect of Okra (International journal of biomaterials · 2019
    Article
  16. Investigation on the Antibacterial and Anti-T3SS Activity of Traditional Myanmar Medicinal Plants.Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mohammed A BaghdadiDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia. m-baghdadi@hotmail.com.ORCID 0000-0003-1469-3074
Fahad A Al-AbbasiDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia. alabassif@hotmail.com.
Ali M El-HalawanyPharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. ahalawany2003@yahoo.com.
Ali H AseeriMinistry of Health, Jeddah 21484, Saudi Arabia. alhaseeri@moh.gov.sa.
Ahmed M Al-AbdStem Cell Research Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia. ahmedmalabd@pharma.asu.edu.eg.ORCID 0000-0001-7872-4867
King Abdulaziz University · SACairo University · EGMinistry of Health · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Napthoquinones and coumarins are naturally occurring compounds with potential anticancer activity. In the current study, two

Indexed as

Antineoplastic Agents, PhytogenicATP Binding Cassette Transporter, Subfamily BCaco-2 CellsCell ProliferationCell SurvivalCoumarinsDown-RegulationDrug SynergismGene Expression Regulation, NeoplasticHeLa CellsHep G2 CellsHumansIn Vitro TechniquesMalvaceaeMCF-7 CellsMolecular StructureABCB1 protein, humanAntineoplastic Agents, PhytogenicATP Binding Cassette Transporter, Subfamily BCoumarinsNaphthoquinonesPaclitaxelPlant Extractscell cyclecolorectal cancercoumarinsMansonia gageimansorin-IIO-naphthoquinonespaclitaxelP-glycoprotein

Identifiers

PMID29701706
PMCPMC6102575
OpenAlexW2800618920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.